The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 44-51

  Jones, Monica Brown ^a   Michener, Chad M ^a   Blanchette, James O ^a   Kuznetsov, Vladimir N ^b   Raffeld, Mark ^a   Serrero, Ginette ^c,d   Emmert Buck, Michael R ^a   Petricoin, Emanuel F ^e   Krizman, David B ^a   Liotta, Lance A ^a   Kohn, Elise C ^a,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f Laboratory of Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULIN EPITHELIN PRECURSOR CELL DERIVED GROWTH FACTOR; GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE S PHASE; CLINICAL ARTICLE; DNA LIBRARY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

CELL DIVISION; CLONING, MOLECULAR; DATABASES; DNA, COMPLEMENTARY; EPITHELIUM; FEMALE; GENE LIBRARY; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIGENE FAMILY; OLIGONUCLEOTIDES, ANTISENSE; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 12244281813     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fang, X., Gaudette, D., Furui, T., Mao, M., Estrella, V., Eder, A., Pustilnik, T., Sasagawa, T., Lapushin, R., Yu, S., Jaffe, R. B., Wiener, J. R., Erickson, J. R., and Mills, G. B. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. N. Y. Acad. Sci., 905: 188-208, 2000.
2. Berchuck, A., Rodriguez, G., Olt, G., Whitaker, R., Boente, M. P., Arrick, B. A., Clarke-Pearson, D. L., and Bast, R. C. J. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol., 166: 676-684, 1992.
3. Hurteau, J. A., Allison, B., Sutton, G. P., Moore, D. H., Look, K. Y., Hurd, W., and Bigsby, R. M. Transforming growth factor-β differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1. Cancer (Phila.), 85: 1810-1815, 1999.
4. Kawakami, Y., Nagai, N., Ohama, K., Zeki, K., Kuroda, E., and Yamashita, U. Macrophage-colony stimulating factor inhibits the growth of human ovarian cancer cells in vitro. Eur. J. Cancer, 36: 1991-1997, 2000.
5. Furui, T., LaPushin, R., Mao, M., Khan, H., Watt, S. R., Watt, M. A., Lu, Y., Fang, X., Tsutsui, S., Siddik, Z. H., Bast, R. C., and Mills, G. B. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin. Cancer Res., 5: 430-4318, 1999.
6. Toy, E. P., Chambers, J. T., Kacinski, B. M., Flick, M. B., and Chambers, S. K. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol. Oncol., 80: 194-200, 2001.
7. Brown, M. R., Kohn, E. C., and Hutter, R. V. The new millennium: applying novel technology to the study of the cancer cell in situ. Cancer (Phila.), 88: 2-5, 2000.
8. Taylor, H. C. Malignant and semi-malignant tumors of the ovary. Surg. Gyn. Obstet., 48: 204-230, 1929.
9. Link, C. J., Reed, E., Sarosy, G., and Kohn, E. C. Borderline ovarian tumors. Am. J. Med., 101: 217-225, 1996.
10. Kennedy, A. W., and Hart, W. R. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis and transformation to invasive serous carcinoma. Cancer (Phila.), 78: 278-286, 1996.
11. Link, C. J., Kohn, E., and Reed, E. The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: epidemiologic, pathologic, and molecular aspects. Gynecol. Oncol., 60: 347-354, 1996.
12. Hoskins, W. J., Perez, C. A., and Young, R. C. Epithelial ovarian cancer. In: R. F. Ozols, S. C. Rubin, G. M. Thomas, and S. J. Robboy (eds.), Principles and Practice of Gynecologic Oncology, Ed. 3, pp. 981-999. Philadelphia: Lippincott Williams and Wilkins, 2000.
13. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhengping, Z., Goldstein, S. R., Weiss, R. A., and Liotta, L. A. Laser capture microdissection. Science (Wash. DC), 274: 998-1001, 1996.
14. Peterson, L. A., Brown, M. R., Carlisle, A. J., Kohn, E. C., Liotta, L., Emmert-Buck, M. R., and Krizman, D. B. An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res., 58: 5326-5328, 1998.
15. Bhandari, V., and Bateman, A. Structure and chromosomal location of the human granulin gene. Biochem. Biophys. Res. Commun., 188: 57-63, 1992.
16. Brown, M. R., Chuaqui, R., Vocke, C. D., Berchuck, A., Middleton, L. P., Emmert-Buck, M. R., and Kohn, E. C. Allelic loss on chromosome arm 8p: analysis of low malignant potential and invasive epithelial ovarian tumors. Gynecol. Oncol., 74: 98-102, 1999.
17. Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K., and Mattick, J. S. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acid Res., 19: 4008, 1991.
18. Zhang, H., and Serrero, G. Inhibition of the tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor). Proc. Natl. Acad. Sci. USA, 95: 14202-14207, 1998.
19. Kohn, E. C., Sandeen, M. A., and Liotta, L. A. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res., 52: 3208-3212, 1992.
20. Bhandari, V., Palfree, R. G. E., and Bateman, A. Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proc. Natl. Acad. Sci. USA, 89: 1715-1719, 1992.
21. Plowman, G. D., Green, J. M., Neubauer, M. G., Buckley, S. D., McDonald, V. L., Todaro, G. J., and Shoyab, M. The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J. Biol. Chem., 267: 13073-13078, 1992.
22. Bateman, A., Belcourt, D., Bennett, H. P. J., Lazure, C., and Solomon, S. Granulins, a novel class of peptide from leukocytes. Biochem. Biophys. Res. Commun., 173: 1161-1168, 1990.
23. Bhandari, V., Giaid, A., and Bateman, A. The complementary deoxyribonucleic acid sequence, tissue distribution and cellular localization of the rat granulin precursor. Endocrinology, 133: 2682-2689, 1993.
24. Sparro, G. M., Gladenzi, G., Eleuteri, A. M., Angeletti, M., Schroeder, W., and Fioretti, E. Isolation and N-terminal sequence of multiple forms of granulins in human urine. Protein Expr. Purif., 10: 169-174, 1997.
25. Zhou, J., Gao, G., Crabb, J. W., and Serrero, G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J. Biol. Chem., 268: 10863-10869, 1993.
26. Shoyab, M., McDonald, V. L., Byles, C., Todaro, G. J., and Plowman, G. D. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc. Natl. Acad. Sci. USA. 87: 7912-7916, 1990.
27. Liau, L. M., Lallone, R. L., Seitz, R. S., Buznikov, A., Gregg, J. P., Kornblum, H. I., Nelson, S. F., and Bronstein, J. M. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res., 60: 1353-1360, 2000.
28. Lu, R., and Serrero, G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc. Natl. Acad. Sci. USA, 97: 3993-3998, 2000.
29. Lu, R., and Serrero, G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC cell-derived growth factor (PCDGF/granulin precursor). Proc. Natl. Acad. Sci. USA, 98: 142-147, 2001.
30. Lu, R., and Serrero, G. Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells. Biochem. Biophys. Res. Commun., 256: 204-207, 1999.
31. Donald, C. D., Laddu, A., Chandham, P., Lim, S. D., Cohen, C., Amin, M., Gerton, G. L., Marshall, F. F., and Petros, J. A. Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in the renal epithelium. Anticancer Res., 21: 3739-3742, 2001.
32. Line, A., Stengrevics, A., Slucka, Z., Li, G., Jankevics, E., and Rees, R. C. Serological identification and expression analysis of gastric cancer-associated genes. Br. J. Cancer, 86: 1824-1830, 2002.
33. Markert, J. M., Fuller, C. M., Gillespie, G. Y., Bubien, J. K., McLean, L. A., Hong, R. L., Lee, K., Gullans, S. R., Mapstone, T. B., and Benos, D. J. Differential gene expression profiling in human brain tumors. Physiol. Genomics, 5: 21-33, 2001.
34. Daniel, R., He, Z. K., Carmichael, P., Halper, J., and Bateman, A. Cellular localization of gene expression for progranulin. J. Histochem. Cytochem., 48: 999-1009, 2000.
35. Suzuki, M., Bannai, M., Matsumuro, M., Furuhata, Y., Ikemura, R., Kuranaga, E., Kaneda, Y., Nishihara, M., and Takahashi, M. Suppression of copulatory behavior by intracerebroventricular infusion of antisense oligodeoxynucleotide of granulin in neonatal male rats. Physiol. Behav., 68: 707-713, 2000.
36. Diaz-Cueto, L., Stein, P., Jacobs, A., Schultz, R. M., and Gerton, G. L. Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev. Biol., 217: 406-418, 2000.
37. Liotta, L. A., and Kohn, E. C. The microenvironment of the tumor-host invasion field. Nature (Lond.), 411: 375-379, 2001.
38. Zanocco-Marani, T., Bateman, A., Romano, G., Valentinis, B., He, Z. H., and Baserga, R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res., 59: 5331-5340, 1999.
39. Xu, S. Q., Tang, D., Chamberlain, S., Pronk, G., Masiarz, F. R., Kaur, S., Prisco, M., Zanocco-Marani, T., and Baserga, R. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor I receptor for growth in vitro. J. Biol. Chem., 273: 20078-20083, 1998.